LAVA Therapeutics N.V. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.20 | -$0.20 | -$0.20 |
| Q2 2024 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q3 2024 | 2 | -$0.33 | -$0.25 | -$0.30 |
| Q4 2024 | 1 | -$0.27 | -$0.27 | -$0.27 |
| Q1 2025 | 1 | -$0.62 | -$0.62 | -$0.62 |
| Q2 2025 | 1 | -$0.52 | -$0.52 | -$0.52 |
| Q3 2025 | 1 | -$0.46 | -$0.46 | -$0.46 |
| Q4 2025 | 1 | -$0.47 | -$0.47 | -$0.47 |
LAVA Therapeutics N.V. Earnings Date And Information
LAVA Therapeutics N.V. last posted its earnings results on Tuesday, August 20th, 2024. The company reported $-0.31 earnings per share for the quarter, topping analysts' consensus estimates of $-0.33 by $0.02. The company had revenue of 0 for the quarter and had revenue of 6.77 M for the year. LAVA Therapeutics N.V. has generated $-2 earnings per share over the last year ($-1.57 diluted earnings per share) and currently has a price-to-earnings ratio of -1.84. LAVA Therapeutics N.V. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based on prior year's report dates.
LAVA Therapeutics N.V. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/28/2024 | Q2 2024 | -$0.31 | $0 | $0 | ||
| 03/29/2024 | Q1 2024 | -$0.02 | $6.99 M | |||
| 03/20/2024 | Q4 2023 | $0.16 | -$0.24 | -0.4 | $353,000 | |
| 09/29/2023 | Q3 2023 | -$0.34 | $53,000 | |||
| 06/30/2023 | Q2 2023 | -$0.48 | $573,055 | $5.14 M | ||
| 03/31/2023 | Q1 2023 | -$0.53 | $1.22 M | |||
| 04/11/2023 | Q4 2022 | -$0.57 | $2.64 M | |||
| 09/29/2022 | Q3 2022 | $0.04 | $255,972 | $15.26 M | ||
| 06/29/2022 | Q2 2022 | -$0.31 | $777,171 | $468,000 | ||
| 03/30/2022 | Q1 2022 | -$0.38 | $1.02 M | |||
| 03/24/2022 | Q4 2021 | -$0.38 | -$0.32 | 0.06 | $1.07 M | |
| 09/29/2021 | Q3 2021 | -$0.27 | $322,636 | $2.10 M | ||
| 06/29/2021 | Q2 2021 | -$0.31 | $1.08 M | |||
| 03/30/2021 | Q1 2021 | -$12.14 | $1.00 M | |||
| 12/31/2020 | Q4 2020 | -$9.44 | $1.76 M | |||
| 09/29/2020 | Q3 2020 | -$9.37 | $969,746 | |||
| 06/29/2020 | Q2 2020 | -$8.71 | $665,243 | |||
| 03/30/2020 | Q1 2020 | -$9.06 | $0 | |||
| 09/29/2019 | Q3 2019 | -$0.13 | $0 | |||
| 06/29/2019 | Q2 2019 | -$0.14 | $0 |
LAVA Therapeutics N.V. Earnings: Frequently Asked Questions
-
When is LAVA Therapeutics N.V.'s earnings date?
LAVA Therapeutics N.V. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates.
-
Did LAVA Therapeutics N.V. beat their earnings estimates last quarter?
In the previous quarter, LAVA Therapeutics N.V. (:LVTX) reported $-0.31 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.33 by $0.02.
-
How can I listen to LAVA Therapeutics N.V.'s earnings conference call?
The conference call for LAVA Therapeutics N.V.'s latest earnings report can be listened to online.
-
How can I read LAVA Therapeutics N.V.'s conference call transcript?
The conference call transcript for LAVA Therapeutics N.V.'s latest earnings report can be read online.
-
How much revenue does LAVA Therapeutics N.V. generate each year?
LAVA Therapeutics N.V. (:LVTX) has a recorded annual revenue of $6.77 M.
-
How much profit does LAVA Therapeutics N.V. generate each year?
LAVA Therapeutics N.V. (:LVTX) has a recorded net income of $6.77 M. LAVA Therapeutics N.V. has generated $-1.57 earnings per share over the last four quarters.
-
What is LAVA Therapeutics N.V.'s price-to-earnings ratio?
LAVA Therapeutics N.V. (:LVTX) has a price-to-earnings ratio of -1.84 and price/earnings-to-growth ratio is -0.12.
